RESEARCH-USE BIOSIMILAR ANTIBODY
Samalizumab
Monoclonal antibody · IgG2
Samalizumab (ALXN 6000) is a humanized monoclonal antibody that specifically binds to CD200 and blocks its ligation to the CD200 receptor (CD200R). Samalizumab can be used for multiple myeloma and B-cell chronic lymphocytic leukemia research.
TARGETMOX2
YMonoclonal antibody
CATALOGSC-BS-183
CATALOG NUMBERSC-BS-183
MOLECULAR WEIGHTApprox. 144.84 kDa
PRODUCT FORMATMonoclonal antibody
PRODUCT OVERVIEW
A research-use configuration for comparative antibody studies
Samalizumab (ALXN 6000) is a humanized monoclonal antibody that specifically binds to CD200 and blocks its ligation to the CD200 receptor (CD200R). Samalizumab can be used for multiple myeloma and B-cell chronic lymphocytic leukemia research.
Samalizumab is a recombinant research-use antibody directed against MOX2.